Publications by authors named "Jack Kuipers"

Article Synopsis
  • Deep single-cell multi-omic profiling is an innovative method to study drug resistance in relapsed or refractory acute myeloid leukemia (AML).
  • The research combines various single-cell analyses and clinical data from 21 patients, revealing that treatment with both a hypomethylating agent and the Bcl-2 inhibitor venetoclax leads to reduced drug responsiveness compared to other treatment sequences.
  • The study identifies both known and new resistance mechanisms, suggesting alternative therapies like the PLK inhibitor volasertib and highlighting the potential of targeting CD36 in treatment-resistant AML blasts.
View Article and Find Full Text PDF
Article Synopsis
  • Acute myeloid leukemia (AML) is characterized by a complex mix of mutations and generally has a poor prognosis, making understanding the sequence of these mutations important for clinical outcomes.
  • Researchers analyzed single-cell DNA sequencing data from 207 AML patients to investigate how the order of mutations impacted patient features and disease outcomes, revealing that mutations linked to DNA methylation typically occurred before those related to cell signaling.
  • Though some mutation orderings indicated worse prognosis, it was primarily the presence of specific unfavorable mutations that contributed to prognosis, rather than the order itself, highlighting the complex nature of AML's mutation landscape.
View Article and Find Full Text PDF

Acute myeloid leukemia (AML) has a poor prognosis and a heterogeneous mutation landscape. Although common mutations are well-studied, little research has characterized how the sequence of mutations relates to clinical features. Using published, single-cell DNA sequencing data from three institutions, we compared clonal evolution patterns in AML to patient characteristics, disease phenotype, and outcomes.

View Article and Find Full Text PDF

We develop a semiclassical approach for the statistics of the time delay in quantum chaotic systems in the presence of a tunnel barrier, for broken time-reversal symmetry. Results are obtained as asymptotic series in powers of the reflectivity of the barrier, with coefficients that are rational functions of the channel number. Exact expressions, valid for arbitrary reflectivity and channel number, are conjectured and numerically verified for specific families of statistical moments.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on how cell lineages can accumulate mutations as organisms develop, which may lead to disease.
  • Researchers created a new statistical test, called the Poisson Tree (PT) test, to measure the varying rates of evolution among cell lineages using single-cell DNA sequencing (scDNA-seq) data.
  • Their analysis of 24 cancer and healthy samples showed that most samples displayed fluctuating evolutionary rates, particularly in cancer, identifying specific mutations in driver genes that account for these changes.
View Article and Find Full Text PDF

Reconstructing the history of somatic DNA alterations can help understand the evolution of a tumor and predict its resistance to treatment. Single-cell DNA sequencing (scDNAseq) can be used to investigate clonal heterogeneity and to inform phylogeny reconstruction. However, most existing phylogenetic methods for scDNAseq data are designed either for single nucleotide variants (SNVs) or for large copy number alterations (CNAs), or are not applicable to targeted sequencing.

View Article and Find Full Text PDF

Background: Sexual abuse and bullying are associated with poor mental health in adulthood. We previously established a clear relationship between bullying and symptoms of psychosis. Similarly, we would expect sexual abuse to be linked to the emergence of psychotic symptoms, through effects on negative affect.

View Article and Find Full Text PDF

Cancer progression is an evolutionary process shaped by both deterministic and stochastic forces. Multi-region and single-cell sequencing of tumors enable high-resolution reconstruction of the mutational history of each tumor and highlight the extensive diversity across tumors and patients. Resolving the interactions among mutations and recovering recurrent evolutionary processes may offer greater opportunities for successful therapeutic strategies.

View Article and Find Full Text PDF
Article Synopsis
  • SIEVE is a new statistical method designed to analyze genetic data from single-cell DNA sequencing, focusing on identifying somatic variants and understanding cell lineage.* -
  • It improves on existing techniques by using raw read counts and correcting biases in estimating branch lengths, showing better performance in both phylogenetic reconstruction and variant calling, especially for homozygous variants.* -
  • When applied to datasets for triple-negative breast cancer and colorectal cancer, SIEVE revealed that double mutant genotypes are uncommon in colorectal cancer but surprisingly common in triple-negative breast cancer samples.*
View Article and Find Full Text PDF

Comprehensive molecular characterization of cancer subtypes is essential for predicting clinical outcomes and searching for personalized treatments. We present bnClustOmics, a statistical model and computational tool for multi-omics unsupervised clustering, which serves a dual purpose: Clustering patient samples based on a Bayesian network mixture model and learning the networks of omics variables representing these clusters. The discovered networks encode interactions among all omics variables and provide a molecular characterization of each patient subgroup.

View Article and Find Full Text PDF

Motivation: Tumours evolve as heterogeneous populations of cells, which may be distinguished by different genomic aberrations. The resulting intra-tumour heterogeneity plays an important role in cancer patient relapse and treatment failure, so that obtaining a clear understanding of each patient's tumour composition and evolutionary history is key for personalized therapies. Single-cell sequencing (SCS) now provides the possibility to resolve tumour heterogeneity at the highest resolution of individual tumour cells, but brings with it challenges related to the particular noise profiles of the sequencing protocols as well as the complexity of the underlying evolutionary process.

View Article and Find Full Text PDF

Dynamic Bayesian networks (DBNs) can be used for the discovery of gene regulatory networks (GRNs) from time series gene expression data. Here, we suggest a strategy for learning DBNs from gene expression data by employing a Bayesian approach that is scalable to large networks and is targeted at learning models with high predictive accuracy. Our framework can be used to learn DBNs for multiple groups of samples and highlight differences and similarities in their GRNs.

View Article and Find Full Text PDF

Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful technique to decipher tissue composition at the single-cell level and to inform on disease mechanisms, tumor heterogeneity, and the state of the immune microenvironment. Although multiple methods for the computational analysis of scRNA-seq data exist, their application in a clinical setting demands standardized and reproducible workflows, targeted to extract, condense, and display the clinically relevant information. To this end, we designed scAmpi (Single Cell Analysis mRNA pipeline), a workflow that facilitates scRNA-seq analysis from raw read processing to informing on sample composition, clinically relevant gene and pathway alterations, and in silico identification of personalized candidate drug treatments.

View Article and Find Full Text PDF

Tumour progression is an evolutionary process in which different clones evolve over time, leading to intra-tumour heterogeneity. Interactions between clones can affect tumour evolution and hence disease progression and treatment outcome. Intra-tumoural pairs of mutations that are overrepresented in a co-occurring or clonally exclusive fashion over a cohort of patient samples may be suggestive of a synergistic effect between the different clones carrying these mutations.

View Article and Find Full Text PDF

Although combination antiretroviral therapies seem to be effective at controlling HIV-1 infections regardless of the viral subtype, there is increasing evidence for subtype-specific drug resistance mutations. The order and rates at which resistance mutations accumulate in different subtypes also remain poorly understood. Most of this knowledge is derived from studies of subtype B genotypes, despite not being the most abundant subtype worldwide.

View Article and Find Full Text PDF

Background: Recent network models propose that mutual interaction between symptoms has an important bearing on the onset of schizophrenic disorder. In particular, cross-sectional studies suggest that affective symptoms may influence the emergence of psychotic symptoms. However, longitudinal analysis offers a more compelling test for causation: the European Schizophrenia Cohort (EuroSC) provides data suitable for this purpose.

View Article and Find Full Text PDF

We present an in-depth study of the universal correlations of scattering-matrix entries required in the framework of nonstationary many-body scattering of noninteracting indistinguishable particles where the incoming states are localized wave packets. Contrary to the stationary case, the emergence of universal signatures of chaotic dynamics in dynamical observables manifests itself in the emergence of universal correlations of the scattering matrix at different energies. We use a semiclassical theory based on interfering paths, numerical wave function based simulations, and numerical averaging over random-matrix ensembles to calculate such correlations and compare with experimental measurements in microwave graphs, finding excellent agreement.

View Article and Find Full Text PDF

Intra-tumour heterogeneity is the molecular hallmark of renal cancer, and the molecular tumour composition determines the treatment outcome of renal cancer patients. In renal cancer tumourigenesis, in general, different tumour clones evolve over time. We analysed intra-tumour heterogeneity and subclonal mutation patterns in 178 tumour samples obtained from 89 clear cell renal cell carcinoma patients.

View Article and Find Full Text PDF

The application and integration of molecular profiling technologies create novel opportunities for personalized medicine. Here, we introduce the Tumor Profiler Study, an observational trial combining a prospective diagnostic approach to assess the relevance of in-depth tumor profiling to support clinical decision-making with an exploratory approach to improve the biological understanding of the disease.

View Article and Find Full Text PDF

Clonal diversity is a consequence of cancer cell evolution driven by Darwinian selection. Precise characterization of clonal architecture is essential to understand the evolutionary history of tumor development and its association with treatment resistance. Here, using a single-cell DNA sequencing, we report the clonal architecture and mutational histories of 123 acute myeloid leukemia (AML) patients.

View Article and Find Full Text PDF

Germinal centers (GCs) are specialized compartments within the secondary lymphoid organs where B cells proliferate, differentiate, and mutate their antibody genes in response to the presence of foreign antigens. Through the GC lifespan, interclonal competition between B cells leads to increased affinity of the B cell receptors for antigens accompanied by a loss of clonal diversity, although the mechanisms underlying clonal dynamics are not completely understood. We present here a multi-scale quantitative model of the GC reaction that integrates an intracellular component, accounting for the genetic events that shape B cell differentiation, and an extracellular stochastic component, which accounts for the random cellular interactions within the GC.

View Article and Find Full Text PDF

Despite advances in the modeling and understanding of colorectal cancer development, the dynamics of the progression from benign adenomatous polyp to colorectal carcinoma are still not fully resolved. To take advantage of adenoma size and prevalence data in the National Endoscopic Database of the Clinical Outcomes Research Initiative (CORI) as well as colorectal cancer incidence and size data from the Surveillance Epidemiology and End Results (SEER) database, we construct a two-type branching process model with compartments representing adenoma and carcinoma cells. To perform parameter inference we present a new large-size approximation to the size distribution of the cancer compartment and validate our approach on simulated data.

View Article and Find Full Text PDF